Ledger.Open graph →
SEC Form D · filed April 17, 2019

Neuraptive Therapeutics, Inc

Offering
$12.5M
Sold
$10.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Louisville, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Greg Parekh · Philadelphia, PADirectorIvan Gergel · Philadelphia, PADirectorRandy Hubbell · Pittsburgh, PADirectorDavid Jackson · Vancouver, British Columbia, CanadaExec · DirectorGino Disciullo · Broomfield, CODirectorDavid Jackson · VANCOUVER, British Columbia, CanadaExec · DirectorGino Disciullo · DENVER, CODirectorGreg Parekh · Philadelphia, PADirectorIvan Gergel · Philadelphia, PADirectorRandy Hubbell · Pittsburgh, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗